BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lovastatin
,
rs2300478
,
PPARA
,
Apoptosis
,
Allergy to pollen
,
Neuron
,
DNA fingerprint
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
responses type I interferons
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency.
Breaking down the cellular responses to type I interferon neurotoxicity in the brain.
B cell depletion impairs vaccination-induced CD8+ T cell responses in a type I interferon-dependent …
PD-L1 sustains chronic, cancer cell-intrinsic responses to type I interferon, enhancing resistance t…
Characterization of feline TRIM genes: molecular cloning, expression in tissues, and response to typ…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Fai…
Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa
Genetic and Biochemical Markers of Interferon-Induced Depression.
Recombinant Interferon Alfa-2b in Treating Patients With Melanoma
Systemic Therapy With Interferon, Interleukin-2 and BRAF Inhibitor
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ